Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
OtherBasic Science Investigations

Quantitative Analysis of (−)-N-11C-Propyl-Norapomorphine In Vivo Binding in Nonhuman Primates

Dah-Ren Hwang, Rajesh Narendran, Yiyun Huang, Mark Slifstein, Peter S. Talbot, Yasuhiko Sudo, Bart N. Van Berckel, Lawrence S. Kegeles, Diana Martinez and Marc Laruelle
Journal of Nuclear Medicine February 2004, 45 (2) 338-346;
Dah-Ren Hwang
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rajesh Narendran
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yiyun Huang
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mark Slifstein
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter S. Talbot
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yasuhiko Sudo
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bart N. Van Berckel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lawrence S. Kegeles
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Diana Martinez
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marc Laruelle
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • FIGURE 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 1.

    Mean ± SD fraction of plasma activity corresponding to the parent compound over time, after injection of 11C-NPA in baboons (n = 8).

  • FIGURE 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 2.

    Plasma 11C-NPA measurements in a typical experiment. ○ = total plasma activities; • = activities corresponding to unmetabolized 11C-NPA. Lines are values fitted to a sum of 3 exponentials.

  • FIGURE 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 3.

    Voxelwise V3″ map from a study (A) with coregistered MRI (B) of corresponding slices. Transaxial, coronal, and sagittal views are shown (left to right), all at the level of the striatum. These images were created by deriving VT in each voxel with kinetic analysis (1TCM) and applying Equation 3 on each voxel. Colors were scaled to V3″ values (0–2.8). Kinetic analysis was performed using a basis function approach (27) in the MATLAB environment on a 1.2-GHz personal computer running the Linux operating system and completed in approximately 15 min per brain.

  • FIGURE 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 4.

    Time-activity curves in cerebellum (○) and striatum (•) after injection of 11C-NPA. Points are measured values. Lines are values fitted to a 1TCM.

  • FIGURE 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 5.

    Relationship between scan duration and estimates of striatum V3″ by kinetic analysis. For each scan duration, estimated V3″ values were expressed in percentages of the value derived with the complete dataset (90 min). Each point is the average and SD of the 8 datasets. Decreasing the duration of scanning time from 90 to 30 min would induce only small biases and errors (<10%) on the estimates of V3″.

Tables

  • Figures
    • View popup
    TABLE 1

    11C-NPA Peripheral Parameters*

    Baboonf1Vbol (L)CL (L/h)
    A5.0% ± 0.9%3.5 ± 0.530 ± 7
    B4.8% ± 0.6%3.1 ± 0.129 ± 5
    Average4.9% ± 0.1%3.3 ± 0.329 ± 1
    • ↵* Values are mean ± SD; n = 4 per baboon.

    • View popup
    TABLE 2

    Comparison of Compartment Models for 11C-NPA Kinetic Analysis*

    RegionModelVT (mL/g)SE (%CV)Goodness of fit AIC
    Cerebellum1TCM3.4 ± 0.53.3 ± 1.2−29 ± 29
    2TCM3.3 ± 0.5†13.6 ± 8.0†−31 ± 32
    Striatum1TCM7.5 ± 1.51.9 ± 0.8−25 ± 38
    2TCM7.3 ± 1.4†4.5 ± 2.4†−24 ± 37
    • ↵* Values are mean ± SD; n = 8.

    • ↵† Significantly different from 1TCM (paired t test; P < 0.05).

    • View popup
    TABLE 3

    Fractional Rate Constants and Total Distribution Volumes of 11C-NPA in Baboons*

    BaboonCerebellumStriatum
    Kinetic analysisGraphical analysis with arterial inputKinetic analysisGraphical analysis with arterial input
    K1 (mL/g/min)k2 (min)VT (mL/g)(VT [mL/g])K1 (mL/g/min)k2 (min)VT (mL/g)(VT [mL/g])
    A1.06 ± 0.210.29 ± 0.053.72 ± 0.533.39 ± 0.451.11 ± 0.280.13 ± 0.038.50 ± 1.518.02 ± 1.40
    B0.76 ± 0.11†0.24 ± 0.043.17 ± 0.312.90 ± 0.260.67 ± 0.13†0.10 ± 0.026.47 ± 0.97†6.07 ± 0.71†
    Mean0.91 ± 0.210.27 ± 0.033.44 ± 0.393.15 ± 0.35‡0.89 ± 0.310.12 ± 0.027.48 ± 1.447.05 ± 1.38‡
    • ↵* Values are mean ± SD; n = 4 per animal.

    • ↵† Significantly different from baboon A (unpaired t test; P < 0.05).

    • ↵‡ Significantly different from values derived with kinetic analysis (paired t test; P < 0.01).

    • View popup
    TABLE 4

    Binding Parameters of 11C-NPA in Baboons*

    BaboonBP (mL/g)V3″ (unitless)
    Kinetic analysisGraphical with arterial inputKinetic analysisGraphical with arterial inputGraphical with reference region inputSRTM analysis
    A4.78 ± 1.024.63 ± 0.981.29 ± 0.171.36 ± 0.171.35 ± 0.171.41 ± 0.18
    B3.30 ± 0.67†3.17 ± 0.50†1.03 ± 0.12†1.09 ± 0.11†1.08 ± 0.11†1.13 ± 0.13†
    Mean4.04 ± 1.053.90 ± 1.03‡1.16 ± 0.181.23 ± 0.19‡1.22 ± 0.17‡1.27 ± 0.19§
    • ↵* Values are mean ± SD; n = 4 per animal.

    • ↵† Significantly different between the 2 baboons (unpaired t test; P < 0.05).

    • ↵‡ Significantly different from values derived with kinetic analysis (paired t test; P < 0.05).

    • ↵§ Significantly different from values derived with kinetic analysis (paired t test; P < 0.001).

    • View popup
    TABLE 5

    Comparison of Outcome Measures Derived with Kinetic, Graphical, and SRTM Analysis

    ComparisonOutcomeDifferenceRegression equation y = mx + cr2
    Graphical with arterial input versus kineticVT CER−9.4% ± 4.7%†0.80x + 0.360.93
    VT STR−6.2% ± 3.7%†0.91x + 0.200.97
    BP−3.5% ± 4.2%*0.95x + 0.040.97
    V3″−5.3% ± 4.0%*0.98x + 0.080.89
    Graphical with reference region input versus kineticV3″−4.5% ± 3.7%*0.99x + 0.050.91
    SRTM versus kineticV3″−8.5% ± 2.5%†1.04x + 0.050.95
    • ↵* Significantly different from values derived with kinetic analysis (paired t test; P < 0.05; n = 8).

    • ↵† Significantly different from values derived with kinetic analysis (paired t test; P < 0.001; n = 8).

PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 45, Issue 2
February 1, 2004
  • Table of Contents
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Quantitative Analysis of (−)-N-11C-Propyl-Norapomorphine In Vivo Binding in Nonhuman Primates
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Quantitative Analysis of (−)-N-11C-Propyl-Norapomorphine In Vivo Binding in Nonhuman Primates
Dah-Ren Hwang, Rajesh Narendran, Yiyun Huang, Mark Slifstein, Peter S. Talbot, Yasuhiko Sudo, Bart N. Van Berckel, Lawrence S. Kegeles, Diana Martinez, Marc Laruelle
Journal of Nuclear Medicine Feb 2004, 45 (2) 338-346;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Quantitative Analysis of (−)-N-11C-Propyl-Norapomorphine In Vivo Binding in Nonhuman Primates
Dah-Ren Hwang, Rajesh Narendran, Yiyun Huang, Mark Slifstein, Peter S. Talbot, Yasuhiko Sudo, Bart N. Van Berckel, Lawrence S. Kegeles, Diana Martinez, Marc Laruelle
Journal of Nuclear Medicine Feb 2004, 45 (2) 338-346;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • Acknowledgments
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • 18F-MCL-524, an 18F-Labeled Dopamine D2 and D3 Receptor Agonist Sensitive to Dopamine: A Preliminary PET Study
  • Human Biodistribution and Dosimetry of the D2/3 Agonist 11C-N-Propylnorapomorphine (11C-NPA) Determined from PET
  • Measurement of the Proportion of D2 Receptors Configured in State of High Affinity for Agonists in Vivo: A Positron Emission Tomography Study Using [11C]N-Propyl-norapomorphine and [11C]Raclopride in Baboons
  • Google Scholar

More in this TOC Section

  • Design and Fabrication of Kidney Phantoms for Internal Radiation Dosimetry Using 3D Printing Technology
  • Synthesis and Biologic Evaluation of Novel 18F-Labeled Probes Targeting Prostate-Specific Membrane Antigen for PET of Prostate Cancer
  • Tumor-Specific Binding of Radiolabeled PEGylated GIRLRG Peptide: A Novel Agent for Targeting Cancers
Show more Basic Science Investigations

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire